[ 1 ] Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020;395(10223):470–3. 链接1

[ 2 ] Ostuzzi G, Papola D, Gastaldon C, Schoretsanitis G, Bertolini F, Amaddeo F, et al. Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations. BMC Med 2020;18:215. 链接1

[ 3 ] WHO coronavirus disease (COVID-19) dashboard [Internet]. Geneva: World Health Organization; c2020 [cited 2020 Sep 2]. Available from: https://covid19.who.int/.

[ 4 ] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395 (10223):497–506. 链接1

[ 5 ] Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20. 链接1

[ 6 ] Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-vessel stroke as a presenting feature of COVID-19 in the young. N Engl J Med 2020;382:e60. 链接1

[ 7 ] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–62. 链接1

[ 8 ] Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020;323(20):2052–9. 链接1

[ 9 ] Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARSCoV-2 admitted to ICUs of the Lombardy Region Italy. JAMA 2020;323 (16):1574–81. 链接1

[10] Dunnmon JA, Yi D, Langlotz CP, Ré C, Rubin DL, Lungren MP. Assessment of convolutional neural networks for automated classification of chest radiographs. Radiology 2019;290(2):537–44. 链接1

[11] Esteva A, Robicquet A, Ramsundar B, Kuleshov V, DePristo M, Chou K, et al. A guide to deep learning in healthcare. Nat Med 2019;25:24–9. 链接1

[12] Zhu H, Cheng C, Yin H, Li X, Zuo P, Ding J, et al. Automatic multi-label ECG diagnosis of impulse or conduction abnormalities in patients with deep learning algorithm: a cohort study. Lancet Respir Med. In press.

[13] Ienca M, Vayena E. On the responsible use of digital data to tackle the COVID19 pandemic. Nat Med 2020;26:463–4. 链接1

[14] Apostolopoulos ID, Mpesiana TA. COVID-19: automatic detection from X-ray images utilizing transfer learning with convolutional neural networks. Australas Phys Eng Sci Med 2020;43:635–40. 链接1

[15] Santosh KC. AI-driven tools for coronavirus outbreak: need of active learning and cross-population train/test models on multitudinal/multimodal data. J Med Syst 2020;44:93. 链接1

[16] Ayyoubzadeh SM, Ayyoubzadeh SM, Zahedi H, Ahmadi M, Kalhori SRN. Predicting COVID-19 incidence through analysis of google trends data in Iran: data mining and deep learning pilot study. JMIR Public Health Surveill 2020;6 (2):e18828. 链接1

[17] Yang Z, Zeng Z, Wang K, Wong SS, Liang W, Zanin M, et al. Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions. J Thorac Dis 2020;12(3):165. 链接1

[18] Liu F, Zhang Q, Huang C, Shi C, Wang L, Shi N, et al. CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Theranostics 2020;10(12):5613–22. 链接1

[19] Yan L, Zhang HT, Goncalves J, Xiao Y, Wang M, Guo Y, et al. An interpretable mortality prediction model for COVID-19 patients. Nat Mach Intell 2020;2:283–8. 链接1

[20] Cai Q, Yang M, Liu D, Chen J, Shu D, Xia J, et al. Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering 2020;6 (10):1192–8. 链接1

[21] Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180(7):934–43. 链接1

[22] Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020;5(7):802–10. 链接1

[23] Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19): summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323 (13):1239–42. 链接1

[24] Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020;323 (18):1775–6. 链接1

[25] CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12–March 16, 2020. MMWR Morb Mortal Wkly Rep 2020;69:343–6.

[26] Xie J, Shi D, Bao M, Hu X, Wu W, Sheng J, et al. A predictive nomogram for predicting improved clinical outcome probability in patients with COVID-19 in Zhejiang Province, China. Engineering. In press.

[27] National Health Commission of the People’s Republic of China, National Administration of Traditional Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7). Chin Med J 2020;133(9):1087–95.

[28] Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020;46(5):846–8. 链接1

[29] Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. In press.

[30] Livesey A, Garty F, Shipman A, Shipman K. Lactate dehydrogenase in dermatology practice. Clin Exp Dermatol 2020;45(5):539–43. 链接1

[31] Lambert J, Chevret S. Summary measure of discrimination in survival models based on cumulative/dynamic time-dependent ROC curves. Stat Methods Med Res 2016;25(5):2088–102. 链接1

[32] Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315(8):801–10. 链接1

[33] Chen Y, Wang J, Guo S. Use of CRB-65 and quick sepsis-related organ failure assessment to predict site of care and mortality in pneumonia patients in the emergency department: a retrospective study. Crit Care 2016;20:167. 链接1

[34] Ranzani OT, Prina E, Menéndez R, Ceccato A, Cilloniz C, Mendez R, et al. New sepsis definition (Sepsis-3) and community-acquired pneumonia mortality. A validation and clinical decision-making study. Am J Respir Crit Care Med 2017;196(10):1287–97. 链接1

[35] Ferreira M, Blin T, Collercandy N, Szychowiak P, Dequin PF, Jouan Y, et al. Critically ill SARS-CoV-2-infected patients are not stratified as sepsis by the qSOFA. Ann Intensive Care 2020;10(1):43. 链接1

[36] Santana A, Amorim F, Soares F, de Souza GL, de Jesus AL, Rodrigues T, et al. Comparison of CURB-65 and CRB-65 as predictors of death in communityacquired pneumonia in adults admitted to an ICU. Crit Care 2013;17:39. 链接1

[37] Myers LC, Parodi SM, Escobar GJ, Liu VX. Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California. JAMA 2020;323(21):2195–8. 链接1

[38] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323(11):1061–9. 链接1

[39] Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8(4):420–2. 链接1

[40] Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study. Lancet Respir Med 2020;8 (5):475–81. 链接1

[41] Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Circulation 2015;131:211–9. 链接1